Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?
Authors:
- 1 July 2009
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 76 (1) , 23-31
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Predicting the Risk of Dialysis and Transplant Among Patients With CKD: A Retrospective Cohort StudyAmerican Journal of Kidney Diseases, 2008
- Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney diseaseKidney International, 2008
- End-Stage Renal Disease in the United StatesJournal of the American Society of Nephrology, 2007
- Cellular and Molecular Pathways that Lead to Progression and Regression of Renal FibrogenesisCurrent Molecular Medicine, 2005
- Pathways to nephron loss starting from glomerular diseases—Insights from animal modelsKidney International, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- An update on the referral pattern of patients with end-stage renal diseaseKidney International, 2002
- Renal fibrosis: an updateCurrent Opinion in Nephrology and Hypertension, 2001
- Changing pattern of end-stage renal disease in central and eastern EuropeNephrology Dialysis Transplantation, 2000
- Tubulointerstitial Changes as a Major Determinant in the Progression of Renal DamageAmerican Journal of Kidney Diseases, 1992